KIORA PHARMACEUTICALS INC (KPRX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 17, 2025 | CORRESP | Neutral/Informational | Moderate | Kiora Pharmaceuticals, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking to have the registrati… | Read Filing EDGAR |
| Sep. 16, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 16, 2025, informs Kiora Pharmaceuticals, Inc. that their registration statement on Form S-3, filed the previous day, will not be reviewed by… | Read Filing EDGAR |
| Jul. 1, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Kiora Pharmaceuticals, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company and its management of their respon… | Read Filing EDGAR |
| Jun. 20, 2025 | CORRESP | Concern from SEC | Moderate | Kiora Pharmaceuticals, Inc. has responded to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the present… | Read Filing EDGAR |
| Jun. 10, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of Kiora Pharmaceuticals' Form 10-K for the fiscal year ended December 31, 2024, and has raised several comments regarding the financial sta… | Read Filing EDGAR |